Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD

ClinicalTrials.gov ID: NCT00500071

Public ClinicalTrials.gov record NCT00500071. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 20, 2026, 6:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Open-Label, Multi-Center, Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) 20-70mg in Children Aged 6-12 Diagnosed With ADHD

Study identification

NCT ID
NCT00500071
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Shire
Industry
Enrollment
318 participants

Conditions and interventions

Interventions

  • Vyvanse (lisdexamfetamine dimesylate) Drug

Drug

Eligibility (public fields only)

Age range
6 Years to 12 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 27, 2007
Primary completion
Jan 1, 2008
Completion
Jan 1, 2008
Last update posted
Mar 9, 2022

2007 – 2008

United States locations

U.S. sites
46
U.S. states
18
U.S. cities
45
Facility City State ZIP Site status
Melmed Center Scottsdale Arizona
Valley Clinical Research El Centro California
Peninsula Research Assoc, Inc Rolling Hills Estates California
UCSF-Langely Porter Psych Institute San Francisco California
Encompass Clinical Research Spring Valley California
Shire Clinical Research Site Wildomar California
Sarkis Clinical Trials Gainesville Florida
Shire Clinical Research Site Hialeah Florida
CNS Research Institute, Inc Jacksonville Florida
CORE Research, Inc Maitland Florida
Miami Research Associates Miami Florida
Clinical Neuroscience Solutions, Inc Orlando Florida
Janus Center for Psychiatric Research West Palm Beach Florida
Children's Development Center Winter Park Florida
Capstone Clinical Research Libertyville Illinois
Indiana University School of Medicine Indianapolis Indiana
Shire Clinical Research Site Terre Haute Indiana
Shire Clinical Research Site Newton Kansas
Psychiatric Associates Overland Park Kansas
Kentucky Pediatric/Adult Research Bardstown Kentucky
Shire Clinical Research Site Lexington Kentucky
Pedia Research Owensboro Kentucky
Four Rivers Clinical Research, Inc. Paducah Kentucky
Shire Clinical Research Site Troy Michigan
University of Rochester, School of Medicine and Dentistry Rochester New York
Piedmont Neuropsychiatry Charlotte North Carolina
University Commons Office Park Durham North Carolina
University Hospitals of Cleveland Cleveland Ohio
BHI, Inc. Moore Oklahoma
Shire Clinical Research Site Oklahoma City Oklahoma
Oregon Center for Clinical Investigations, Inc Eugene Oregon
Oregon Center For Clinical Investigations, Inc. Portland Oregon
Summit Research Network Portland Oregon
Oregon Center for Clinical Investigations, Inc. Salem Oregon
ADHD Program, Western Psychiatric Institute and Clinic Pittsburgh Pennsylvania
The Jackson Clinic Jackson Tennessee
Clinical Neuroscience Solutions, Inc Memphis Tennessee
FutureSearch Trials Austin Texas
Claghorn-Lesem Research Clinic Inc. Bellaire Texas
Red Oak Psychiatry Associates P.A. Houston Texas
R/D Clinical Research, Inc. Lake Jackson Texas
ADHD Clinic of San Antonio San Antonio Texas
NeuroScience, Inc Herndon Virginia
Dominion Clinical Research Midlothian Virginia
International Clinical Research Associates, LLC Richmond Virginia
Eastside Therapeutic Resource Kirkland Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00500071, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 9, 2022 · Synced Jul 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00500071 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →